NEW YORK (GenomeWeb News) – Cepheid today said that it will acquire Stretton Scientific, a UK-based distributor of diagnostic and monitoring equipment, for around £1.2 million ($1.9 million).
 
Privately held Stretton already distributes Cepheid’s SmartCycler system to customers, including the National Health Service, throughout the UK. The acquisition is expected to “augment our newly established UK-based direct sales team,” Cepheid CEO John Bishop said in a statement.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.